Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Gut Microbiota on Immune Responses and Protection in Volunteers Receiving the Live Attenuated Oral ETEC Vaccine ACE257 followed by Virulent ETEC H10407 Challenge.

Research square·2026
Same author

Improving cholera vaccination impact through advances in gut mucosal immunology: outcomes of a 2025 expert consultation.

Vaccine·2026
Same author

Integrating ethical analysis in health technology assessment: opportunities and challenges.

International journal of technology assessment in health care·2026
Same author

Faecal Coliforms and <i>Escherichia coli</i> Contamination in Drinking Water Sources in Cholera Hotspot Areas of Lusaka District, Zambia: A Cross-Sectional Study.

Microorganisms·2026
Same author

Factors associated with exclusive breastfeeding at 6 months postpartum: a prospective mixed-method cohort study.

Pediatric research·2026
Same author

Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities.

Vaccine·2025
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Financing children's vaccines.

E Anthony S Nelson1, David Sack, Lara Wolfson

  • 1Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, PR China. tony-nelson@cuhk.edu.hk

Vaccine
|November 26, 2009
PubMed
Summary
This summary is machine-generated.

Vaccines offer significant economic and health benefits, crucial for disease control and development. Sustainable funding and clear communication are vital for maximizing vaccination impact globally.

More Related Videos

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

Related Experiment Videos

Last Updated: Jun 18, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

Area of Science:

  • Pediatric Gastroenterology and Nutrition
  • Global Health Economics
  • Vaccine Financing

Background:

  • A 2006 workshop emphasized vaccines' role in controlling childhood diseases like diarrhea and promoting economic growth.
  • GAVI and partners have improved vaccine access in low-income nations, but challenges remain for middle- and high-income countries.
  • Effective communication of vaccination value to policymakers is essential for securing sustainable funding.

Purpose of the Study:

  • To highlight the economic and health benefits of childhood immunizations.
  • To discuss strategies for sustainable vaccine financing.
  • To advocate for clear communication of vaccine value to decision-makers.

Main Methods:

  • Review of discussions from a 2006 Commonwealth Association of Paediatric Gastroenterology and Nutrition workshop.
  • Analysis of the progress made by GAVI and partners in vaccine financing.
  • Identification of data resources available from the World Health Organization.

Main Results:

  • Vaccines are recognized as powerful tools for disease prevention and economic development.
  • Sustainable funding mechanisms and clear communication strategies are necessary for successful immunization programs.
  • Existing data from the World Health Organization can support advocacy for the benefits of vaccines.

Conclusions:

  • Investing in vaccines yields substantial health and economic returns.
  • Tailored funding solutions are needed for different income-level countries to achieve universal vaccination.
  • Leveraging available data is key to communicating the value of vaccines to stakeholders.